Overview

Combo-PEP: Multipurpose Prevention of Post-Exposure Prophylaxis Regimens

Status:
Recruiting

Trial end date:
2023-04-01

Target enrollment:

Participant gender:

Summary

The study will determine tissue pharmacology of a single dose of doxycycline for sexually transmitted infection (STI) Post-exposure Prophylaxis (PEP).

Phase:

Phase 4

Details

Lead Sponsor:

Emory University

Collaborator:

Centers for Disease Control and Prevention

Treatments:

Doxycycline